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Abstract
Background: Stenotrophomonas maltophilia is emerging as one of the most frequently found bacteria in cystic
fibrosis (CF) patients. In the present study, phenotypic and genotypic traits of a set of 98 isolates of
S. maltophilia obtained from clinical (CF and non-CF patients) and environmental sources were comparatively
evaluated.
Results: S. maltophilia exhibited a high level of genomic diversity in both CF and non-CF group, thus possibly
allowing this bacterium to expand its pathogenic potentials. Strains sharing the same pulsotype infected different
patients, thus likely indicating the occurrence of clonal spread or acquisition by a common source. CF isolates
differed greatly in some phenotypic traits among each other and also when compared with non-CF isolates,
demonstrating increased mean generation time and susceptibility to oxidative stress, but reduced ability in forming
biofilm. Furthermore, in CF isolates flagella- and type IV pili-based motilities were critical for biofilm development,
although not required for its initiation. Sequential isogenic strains isolated from the same CF patient displayed
heterogeneity in biofilm and other phenotypic traits during the course of chronic infection. CF and non-CF isolates
showed comparable virulence in a mouse model of lung infection.
Conclusions: Overall, the phenotypic differences observed between CF and non-CF isolates may imply different
selective conditions and persistence (adaptation) mechanisms in a hostile and heterogeneous environment such as
CF lung. Molecular elucidation of these mechanisms will be essential to better understand the selective adaptation
in CF airways in order to design improved strategies useful to counteract and eradicate S. maltophilia infection.
Background
Stenotrophomonas maltophilia is a Gram-negative oppor-
tunistic pathogen in hospitalized or compromised
patients [1,2]. In the last decade, it has emerged as one of
the most frequently found bacteria in cystic fibrosis (CF)
patients [3,4]. However, the role of this opportunistic
pathogen as an innocent bystander or causative agent
often remains unclear [5,6] and little is known about its
virulence factors [7-9].
Biofilms, sessile structured bacterial communities
exhibiting recalcitrance to antimicrobial compounds and
persistence despite sustained host defenses, are increas-
ingly recognized as a contributing factor to disease
pathogenesis in CF and other respiratory tract diseases
associated with chronic bacterial infections [10,11].
While S. maltophilia
CF isolates are known to have the ability to form bio-
films on both abiotic surfaces [12-16] and CF-derived
epithelial monolayer [17], it is not clear whether there is
an intrinsic difference in biofilm formation among geno-
mically diverse environmental and clinical isolates of
S. maltophilia.
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in S. maltophilia have not been extensively studied.
Recently, mutants for the glucose-1-phosphate thymidyl-
transferase rmlA gene and for the cis-11-methyl-2-dodece-
noic acid rpfF gene are reported to decrease biofilm
formation [18,19]. Further, the spgM gene, encoding a
bifunctional enzyme with both phosphoglucomutase
(PGM) and phosphomannomutase activities, could be
involved in biofilm-forming ability because of the homology
with the algC gene that is responsible for the production
of a PGM associated with LPS and alginate biosynthesis in
P. aeruginosa [20].
Several typing schemes have been used successfully in
the molecular epidemiology of S. maltophilia strains in
an attempt to investigate the epidemiology of infections
and nosocomial outbreaks caused by this microorganism.
Phenotypic methods - such as serotyping, antibiotyping
a n db i o t y p i n g-h a v ep r o v e nt ob ep o o r l yd i s c r i m i n a t i v e
because of a low interstrain variability [21]. Molecular
typing techniques have been successfully used to study
the epidemiology of S. maltophilia revealing a genetically
high diversity in this species [21-26].
In this study, we examined a set of 98 isolates of
S. maltophilia - obtained from clinical (CF and non-CF
patients) and environmental sources - for phenotypic
(biofilm formation, mean generation time, swimming and
twitching motilities, susceptibility to oxidative stress) and
genotypic (clonal relatedness) traits in order to find sig-
nificant differences among the groups considered. In
addition, the relationship between biofilm production
and the detection of rmlA, spgM,a n drpfF genes was
evaluated. Virulence was also assessed by using an
experimental model of airborne lung infection.
Our results indicate that CF S. maltophilia isolates
s i g n i f i c a n t l yd i f f e ri nm a n yp h e n o t y p i ca s p e c t sw h e n
compared with non-CF isolates, thus suggesting the
existence of a “CF phenotype”.
Results
CF and non-CF isolates exhibit comparable relevant
genetic heterogeneity
As shown in Figure 1, a total of 65 distinct Pulsed-Field
Gel Electrophoresis (PFGE) types were identified among
the 88 S. maltophilia clinical isolates studied: 36 and 29
different PFGE profiles were respectively observed
among non-CF and CF isolates, showing a comparable
genetic heterogeneity (number of pulsotypes/number of
strains tested: 76.6 vs 70.7%, respectively; p > 0.05). No
cases of PFGE types shared by CF and non-CF isolates
were found. Eight PFGE types were represented by mul-
tiple isolates, 5 of which detected among non-CF iso-
lates and 3 among CF isolates.
PFGE of 7 sequential isolates (Sm189, Sm190,
Sm191, Sm192, Sm193, Sm194, and Sm195), collected
from the same CF patient over a period of 5 years,
showed the presence of two different pulsotypes (PFGE
types 23.1 and 46.1). Another case of isolates recovered
from the same patient was represented by isolates
Sm134, Sm135, and Sm136, all sharing PFGE type
23.1. Along with visual interpretation, computer-
assisted cluster analysis by using the Unweighted Pair
Group Method with Arithmetic Averages (UPGMA)
was also performed. Genetically related isolates showed
a similarity of > 90% which corresponded to up to 3
bands of difference between 2 given PFGE profiles.
Among 10 ENV isolates included in this study, 8 dif-
ferent PFGE types were found, with two isolates (C34,
A33) sharing genetically related PFGE type with a non-
CF isolate (Sm184).
CF isolates are less effective than non-CF ones in forming
biofilm
Most of S. maltophilia strains were able to form biofilm,
although a significantly higher proportion of biofilm-
positive strains was observed among non-CF strains,
compared to CF ones (97.9 vs 90.2%, respectively; p =
0.03) (Figure 2).
Biofilm forming ability varied greatly among strains
tested (OD492 range: 0.030-3.646), although values dis-
tribution was significantly less skewed among CF
strains compared to non-CF and ENV strains (coeffi-
cient of variation: 70.0 vs 90.2, and 85.8%, respectively;
p < 0.001). Similarly, among ENV strains variability in
biofilm levels formed at 25°C was significantly lower
than that observed at 37°C (36. 8 vs 85.8%, respec-
tively; p <0 . 0 0 1 ) .
The mean biofilm formed by CF strains as a whole
was significantly lower than that formed by non-CF
strains (OD492, mean ± SD: 0.498 ± 0.348 vs 0.893 ±
0.806, respectively; p < 0.05) (Figure 3A), even after
n o r m a l i z a t i o no nm e a ng e n e r ation time (biofilm/MGT:
0.14 ± 0.11 vs 0.31 ± 0.31; CF vs non -CF strains,
respectively; p < 0.01) (Figure 3B). No difference in bio-
film formation was observed between clinical and ENV
isolates (Figure 3A). With regard to biofilm categories, a
significantly higher percentage of weak and strong bio-
film producers was found in non-CF strains compared
to CF ones (weak: 10.6 vs 2.4%, respectively, p <0 . 0 5 ;
strong: 85.1 vs 63.4%, respectively, p < 0.0001) (Figure
3C). Contrarily, CF group exhibited a significantly
higher proportion of moderate biofilm forming strains
(23.0 vs 2.0%, respectively, p < 0.0001) (Figure 3C). No
significant difference in biofilm levels formed by non-
CF strains was found according to the isolation site,
although among respiratory strains, non-CF strains pro-
duced significantly higher biofilm levels compared to CF
ones (0.960 ± 0.919 vs 0.498 ± 0.348, respectively; p <
0.05) (Figure 3D).
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Figure 1 Clonal relatedness, biofilm formation, and biofilm-associated genotypes of clinical and environmental S. maltophilia strains.
The dendrogram was constructed with PFGE profiles by similarity and clustering analysis by the Dice coefficient and the UPGMA. A percent
genetic similarity scale is showed above the dendrogram. Isolates showing ≥ 90% of similarity (indicated as a dotted line) were considered
genetically related. ID strains, source [non-CF strains are not marked, CF isolates are marked with an asterisk (*), and ENV isolates are indicated
with two asterisks (**)], PFGE types and the 3 major PFGE clusters encountered in this study are also indicated. Sm189, Sm190, Sm191, Sm192,
Sm193, Sm194, and Sm195 isolates were recovered from the same CF patient. Sm134, Sm135, and Sm136 strains are other consecutive isolates
recovered from another CF patient. According to biofilm amount formed, strains were classified as follows: NP (no biofilm producer: OD492 ≤
0.096), W (weak biofilm producer: 0.096 < OD492 ≤ 0.192), M (moderate biofilm producer: 0.192 < OD492 ≤ 0.384), S (strong biofilm producer:
OD492 > 0.384).
a BA genotype, Biofilm-associated genotype. ND, not determined.
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Figure 2 Biofilm formed on polystyrene by 98 clinical and environmental S. maltophilia strains. Biofilm amount formed after 24 h
incubation at 37°C was assessed by microtiter colorimetric assay. Strains from non-CF patients are represented by blue bars, strains from CF
patients are represented by cyan bars, and strains from environmental sources (ENV) are represented by black bars. Each strain was tested in
quadruplicate on two different occasions. Results were subtracted from negative control (OD492 = 0.096) and expressed as means + SDs.
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Figure 3 Biofilm formation on polystyrene, growth rate, and susceptibility to oxidative stress among 98 clinical and environmental S.
maltophilia strains. A. Biofilm levels (mean + SD) formed by CF, non-CF, and ENV (ENV-37: 37°C-grown strains; ENV-25: 25°C-grown strains)
isolates. B. Biofilm formation normalized on mean generation time (MGT) by CF, non-CF, ENV-37, and ENV-25 isolates. C. Percentage distribution
of non-CF (blue bars) and CF (cyan bars) isolates belonging to no (OD492 ≤ 0.096; n = 5), weak (0.096 < OD492 ≤ 0.192; n = 6), moderate (0.192
<O D 492 ≤ 0.384; n = 11), or strong (OD492 > 0.384; n = 66) biofilm producer group. D. Biofilm formation (mean + SD) observed in non-CF
strains, stratified by the isolation site, and CF strains. E. Mean generation time (mean + SD) of CF, non-CF, ENV-37, and ENV-25 isolates. F.
Sensitivity to oxidative stress of CF, non-CF, ENV-37, and ENV-25 isolates. Results are expressed as mean (+ SD) diameter of inhibition zone
formed by each isolate following exposure to 1.5% (vol/vol) H2O2.*p < 0.05 or ** p < 0.01, ANOVA followed by Bonferroni’s multiple
comparison post-test. ° p < 0.05 or °°° p < 0.0001, Fisher’s exact test.
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Page 5 of 16CF isolates grow slower and are more sensitive to H2O2,
compared to non-CF ones
CF isolates showed higher mean generation time com-
pared to non-CF ones (3.5 ± 0.5 h vs 3.1 ± 0.6 h,
respectively; p < 0.001) (Figure 3E). Indeed, ENV isolates
grown at 37°C exhibited a significantly lower generation
time compared to that observed at 25°C (2.5 ± 0.6 h vs
3.2 ± 0.4 h, respectively; p < 0.05) (Figure 3E). No signif-
icant relationship was found between growth rate and
the biofilm biomass formed, regardless of group consid-
ered (data not shown).
Susceptibility to oxidative stress was evaluated by
measuring the zone of inhibition formed by each strain
following exposure to 1.5% H2O2. The mean zone of
inhibition exhibited by CF strains (17.0 ± 1.3 mm)
resulted to be significantly higher than that observed by
non-CF (16.0 ± 1.0 mm; p < 0.01), and ENV strains
(15.6 ± 1.2, and 15.8 ± 1.6 mm, for ENV-25, and ENV-
37, respectively; p < 0.05) (Figure 3F).
Phenotypic characteristics exhibited by CF sequential
isogenic isolates undergo alterations during the course of
chronic infection
Five S. maltophilia strains, isolated from the same CF
patient over a period of 3 years and belonging to the
same pulsotype, were investigated for phenotypic varia-
tions with regard to biofilm formation, mean generation
time, swimming and twitching motility, and susceptibil-
ity to H2O2. As shown in Figure 4A, biofilm amount
formed by Sm192 (strong biofilm producer) was signifi-
cantly (p < 0.001) higher than other genetically indistin-
guishable isolates (moderate biofilm producers).
Spectrophotometric results were confirmed by Confocal
Laser Scanning Microscopy (CLSM) analysis showing
significant differences in biofilm ultrastructure formed
by the sequential isolates (Figures 4B-C). In particular,
the biofilm formed by Sm192 strain resulting to be the
most complex, revealing a multilayered cell structure
(64-70 μm, depth) embedded in an abundant extracellu-
lar polymeric substance (EPS) (Figure 4C). These fea-
tures were not observed for the other isolates showing
either poor attachment (strains Sm194 and Sm195) or
forming monolayer biofilm lacking EPS (strain Sm190)
(Figure 4B).
Significant differences were also found among sequen-
tial isolates in some cases concerning susceptibility to
oxidative stress (Sm194 vs Sm190, p < 0.05; Sm194 vs
Sm192, p < 0.001) and swimming motility (Sm193 vs
Sm194 and Sm195, p < 0.001) (data not shown).
Swimming and twitching motilities are critical for biofilm
development in CF strains
Overall, 9 nonmotile strains, 4 non-CF strains and 5 CF
strains, with neither swimming nor twitching motility
were observed, with only 2 of them resulting in the
inability to form biofilm. No significant differences were
seen in motility, in the percentage of motile strains, and
in the mean motility level between CF and non-CF iso-
lates (data not shown). Similarly, among ENV isolates
growth temperature did not significantly affect neither
swimming nor twitching motility (data not shown).
Interestingly, swimming and twitching motilities were
positively correlated to biofilm biomass (Pearson r:
0.528 and 0.625, respectively; p < 0.0001) in CF strains
only. No statistically significant differences were found
among the motility patterns (swimming+/twitching+,
swimming+/twitching-, swimming-/twitching+, and
swimming-/twitching-) with respect to the biofilm
formed (data not shown).
CF and non-CF isolates show comparable virulence in a
mouse model of lung infection
As shown in Figure 5A, a weight reduction of at least
10% was observed on day 1 post-exposure (p.e.) in mice
infected with invasive Sm46 and Sm188 strains and
those exposed to non-CF Sm174, and later for mice
exposed to CF strains (on day 2 and 3 p.e. for Sm122
and Sm111 strains, respectively). By day 1 p.e. the mean
weight of infected mice was significantly (p <0 . 0 1 )
lower than that of control mice. By day 2 p.e., only
infected mice with non-CF strains (Sm174, Sm170) and
the invasive Sm188 strain slowly started regaining
weight, although only mice infected with Sm170 strain
regained it completely on day 3 p.e.. Control mice lost
not more than 1% of their body weight during the
study-period monitored. All infected mice showed
symptoms of slow responsiveness and piloerection from
day 1 through day 3 p.e..
Lung clearance results of S. maltophilia infection are
summarized in Figure 5B. The initial deposition of
S. maltophilia in the mouse lung was assessed by viable
count 1 h p.e.. All S. maltophilia strains were almost
completely eradicated from mouse lung (> 99%), while
Sm111 CF and Sm46 non-CF blood isolates were eradi-
cated less effectively (0.51 and 0.71% retention, respec-
tively) than non-CF respiratory strains (0.04% retention),
although these differences were not statistically signifi-
cant. No correlation was found between in vitro biofilm
formation and in vivo lung colonization.
Pulmonary levels of cytokines detected on day 3 p.e.
are shown in Figure 5C. Higher levels of TNF-a were
significantly observed in the lungs of mice infected by
Sm111 CF strain, compared to control mice (median:
1.63 vs 0.050 pg/mg, respectively; p < 0.01). Moreover,
higher levels of KC were observed on day 3 p.e. in the
lungs of mice infected by invasive Sm46 strain, com-
pared to control mice (median: 23.28 vs 0.42 pg/mg,
respectively; p < 0.01).
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Figure 4 Biofilm formed by S. maltophilia sequential strains isolated from the same CF patient. A. Biofilm formation on polystyrene,
assessed by microplate colorimetric assay. PFGE analysis revealed that all strains belonged to the same pulsotypes 23.1. *** p < 0.001, Sm192 vs
other strains, ANOVA-test + Bonferroni’s multiple comparison test. B. CLSM examination of biofilm formed by sequential isolates belonging to
pulsotype 23.1 after 24 h of development. C. CLSM examination of S. maltophilia Sm192 biofilm after 24 h of development. Orthogonal images,
collected within the biofilm as indicated by the green and red lines in the top view, showed that biofilm consisted of cells forming a
multilayered structure (red, propidium iodide-stained) embedded in an abundant extracellular polymeric substance (blue, concanavalin
A-stained). Image capture was set for simultaneous visualization of both red and blue fluorescence. Magnification, ×100.
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Figure 5 Mouse model of acute lung infection by C F and non-CF S. maltophilia strains. DBA/2 mice (n = 8, for each strain) were exposed
on day 0 to aerosolized CF (Sm111 and Sm122 strains, from respiratory specimens) or non-CF (Sm170 and Sm174 strains, from respiratory
specimens; Sm46 and Sm188 strains, from blood) S. maltophilia in PBS. Control mice were exposed to aerosolized PBS only. A. Weight
monitoring during S. maltophilia lung infection. Results are expressed as percentage of weight loss with respect to control mice (100%). The
horizontal line shows a 10% weight loss with regard to mean body weight of control mice. Differences in weight reduction were all significant
(p < 0.01, Fisher’s exact test) compared to control mice, except for Sm111 exposed mice at day 1 post-exposure (p.e.). B. S. maltophilia survival in
mouse lungs 3 days p.e.. For each exposure, four mice each were included for determination of bacterial deposition to the lungs at 1 h and 3
days p.e.. Results are expressed as mean + SD. C. Cytokine levels measured on day 3 p.e. in lung homogenates. Results were normalized to the
lung wet weight (pg/mg) and expressed as box and whiskers: the box extends from the 25
th percentile to 75
th percentile, with a line at the
median (50
th percentile); the whiskers indicate the lowest and the highest value. * p < 0.05 or ** p < 0.01, Kruskal-Wallis test followed by Dunn’s
multiple comparison post-test.
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Page 8 of 16Different genotypes are associated to strong biofilm
formation in CF and non-CF isolates
PCR-based typing of 89 (84 clinical, 5 ENV) S. malto-
philia strains for spgM, rmlA, and rpfF genes showed an
overall prevalence of 88.8, 65.2, and 61.8%, respectively.
The presence of rmlA, spgM or rpfF did not signifi-
cantly affect the mean amount of biofilm formed by CF
or non-CF isolates. However,c o n s i d e r i n gt h es t r a i n
population as a whole, the presence of rmlA significantly
improved biofilm formation (0.820 ± 0.785 vs 0.415 ±
0.278, rmlA
+ vs rmlA
-, respectively; p = 0.01).
With regard to biofilm categories, in CF strains display-
ing strong and moderate biofilm-producer phenotype the
frequencies of spgM
+ and rpfF
+ isolates were significantly
(p < 0.01) higher than rmlA
+ ones (strong biofilm produ-
cer: 92.3 vs 84.6 vs 61.5%, respectively; moderate biofilm
producers: 90 vs 60 vs 20%, respectively). Among non-CF
strong biofilm producer strains, frequencies of spgM
+
and rmlA
+ strains were significantly (p < 0.01) higher
than rpfF
+ ones (88.8 vs 83.3 vs 55.5%, respectively).
Eight genotypes were observed with wide range per-
centages (from 1.1 to 34.8%) and those with the high-
est frequency were rmlA
+/spgM
+/rpfF
+ (34.8%), rmlA
-/
spgM
+/rpfF
+ (23.6%), and rmlA
+/spgM
+/rpfF
- (21.3%).
Analysis of molecular variance (AMOVA) followed by
Pairwise Fst values comparison highlighted significant var-
iance (p < 0.01) in genotypes distribution between CF and
non-CF strains, and also between ENV and respectively CF
and non-CF strains. In particular, rmlA
-/spgM
+/rpfF
+ and
rmlA
+/spgM
+/rpfF
- genotypes were differentially observed,
the first one accounting for 71.4% and 28.6% (p < 0.0001)
while the second one for 10.5% and 84.2% (p < 0.0001) in
CF and non-CF strains, respectively (Figure 6A).
Within each group the genotypes did not signifi-
cantly differ for mean amount of biofilm formed (data
not shown). However, with regard to genotype rmlA
+/
spgM
+/rpfF
+ CF isolates formed significantly decreased
biofilm amounts compared to non-CF ones (0.556 ±
0.485 vs 1.110 ± 0.832, respectively; p < 0.05).
The genetic network in Figure 6B shows the proportion
of strong-, moderate-, weak- and no-biofilm producer
strains associated to each observed genotype. Correlation
analysis showed that genotypes differentially detected in
CF (rmlA
-/spgM
+/rpfF
+) and non-CF (rmlA
+/spgM
+/rpfF
-)
strains were both associated to strong biofilm producers
(Pearson r: 0.82, and 0.88 for CF and non-CF strains,
respectively; p < 0.01). However, CF genotypes were also
correlated to no biofilm producer strains (Pearson r =
0.72, p = 0.02) while non-CF strains were correlated to
weak biofilm producer ones (Pearson r = 0.93, p < 0.0001).
Discussion
In the present study, we comparatively studied phenoty-
pic and genotypic traits of 98 S. maltophilia isolates
(41 CF, 47 non-CF, and 10 ENV strains) collected from
geographically diversified areas.
To date, the epidemiology of S. maltophilia in CF
patients has not been fully clarified. Molecular typing
methods revealed a genetically high diversity within
S. maltophilia strains, both from hospitalized CF and non-
CF patients [21-32]. Our results confirmed the high degree
of diversity between isolates from hospitalized CF and
non-CF patients, thus suggesting that CF pulmonary
S. maltophilia infections are mainly associated with a pre-
dominant strain. Nevertheless, we observed several exam-
ples of PFGE types shared by multiple isolates in both CF
(pulsotypes 23.1 and 24.1) and non-CF (pulsotypes 1.1,
2.1, and 3.1) patients. In particular, the major PFGE type
23 clone identified, represented by 4 strains recovered
from non replicate CF patients, likely indicate the occur-
rence of person-to-person transmission of S. maltophilia
strains, the acquisition of this specific clone from a com-
mon source, or an independent acquisition of a widely-
spread strain type. The dissemination and spread of a spe-
cific clone may be due to the circulation of a transmissible
strain among CF patients, probably due to a better fitness
of this specific clone in the CF pulmonary niche or from
an environmental source.
Interestingly, distinct PFGE types were found between
CF isolates and non-CF isolates. Further studies are war-
ranted to evaluate if factors associated to the virulence
could affect this important segregation among these two
settings.
These results could reflect an extensive spread of S.
maltophilia in the environment thus suggesting the exis-
tence of natural reservoirs of bacterial strains able to
cause pathogenicity once acquired by CF patients. Con-
trary to P. aeruginosa, it has not been reported yet that
S. maltophilia is capable of making the transition from
an environmental state to a colonizing state in CF
patients. However, Marzuillo et al [33] found a persis-
tence of the same S. maltophilia strain in water, taps,
and sinks of different rooms of an Italian CF center,
although no correlation was observed between clinical
and water-associated isolates. Furthermore, we recently
observed that environmental S. maltophilia is potentially
virulent, although to a lesser extent than CF one, in a
murine model of lung infection [34]. Moreover, our
results showed that two environmental isolates (C34,
A33) shared genetically related PFGE type with a non-
CF isolate (Sm184). Thus, it is plausible to hypothesize
that the acquisition of pathogenic S. maltophilia strains
can occur directly from the natural environment.
S. maltophilia is capable of adhering to and forming
biofilm not only on polystyrene [12-14,16,35], but also
on CF bronchial epithelial cells [17], suggesting that bio-
film formation could be a critical step in colonisation of
CF lung.
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Page 9 of 16While S. maltophilia possesses complex, diversified
genomes [1] and forms biofilms, it is not yet known
whether there are any variations in biofilm formation
among clonally diverse clinical and environmental iso-
lates. In the present study, microtiter colorimetric
assay for biofilm formation showed a wide range of
biofilm formation ability in both CF and non-CF
groups, from biofilm-deficient phenotypes to those
producing structurally complex biofilms. However,
when grouped, CF isolates were found to form an
amount of biofilm significantly lower compared to that
observed among non-CF isolates. To exclude the possi-
bility that these differences in biofilm formation could
arise from differences in growth efficiency [36], biofilm
levels were normalized on growth rate calculated for
each strain.
 
 


Figure 6 Proportion of S. maltophilia genotypes and association with biofilm formation. A. Genetic network representing proportion of
genotypes found in CF (blue), non-CF (yellow), and ENV (black) strain population. rmlA
-/spgM
+/rpfF
+ genotype was statistically more represented
in CF than non-CF group (71.4 vs 28.6%, respectively; p<0.0001, AMOVA); rmlA
+/spgM
+/rpfF
- genotype was statistically more represented in non-
CF than CF group (84.2 vs 10.5%, respectively; p < 0.0001, AMOVA). B. Genetic network representing association between genotypes and biofilm
formation (red: strong biofilm producers; orange: moderate biofilm producers; yellow: weak biofilm producers; white: no biofilm producers).
rmlA
-/spgM
+/rpfF
+ and rmlA
+/spgM
+/rpfF
- genotypes were statistically associated to strong biofilm producers (Pearson r: 0.82 and 0.88,
respectively; p < 0.01).
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nificantly lower than non-CF ones - probably because of
the phenotypic regulation of virulence factor expression
by quorum sensing mechanisms or by in vivo bacterial
microevolution driven by selective lung environmental
conditions, mechanisms already described in bacteria
[37-39] - significant differences in biofilm formation
were maintained also after normalization, thus indicat-
ing that in S. maltophilia biofilm formation is not influ-
enced by growth rate.
The reduced efficiency in forming biofilm and the
increased mean generation time exhibited by CF isolates
could be the consequences of S. maltophilia adaptation to
a stressed environment such as CF lung [40-42]. To verify
this hypothesis, five isogenic sequential S. maltophilia
strains isolated from the same CF patient over a period of
3 years were investigated for phenotypic variations. Our
results showed that isogenic serial strains significantly dif-
fer in biofilm forming ability, susceptibility to oxidative
stress, and swimming motility suggesting that different S.
maltophilia phenotypes evolve within the CF respiratory
tract during chronic infection. Particularly, the reduction
in biofilm formation ability of sequential isolates is sugges-
tive for the phenotypic conversion of S. maltophilia during
chronic infection. CLSM analysis showed that isolates
from the early periods of chronic infection were able to
form uniform flat biofilms or highly structured, multi-
layered and exopolysaccharide matrix-encased, biofilms.
On the contrary, isolates recovered from the late phase of
chronic infection showed a significant reduction in adher-
ence, lacking ability to form a mature biofilm. Significant
differences were also found with regard to susceptibility to
oxidative stress and swimming motility.
These results suggest that the onset of chronic infection
could be transformative for S. maltophilia,p r o b a b l y
reflecting an adaptive behavior that enables S. maltophilia
to survive to the environmental stresses that are likely to
be encountered within the habitat of the CF lung, such as
(oxidative stress) low free iron, and anaerobic conditions
[43]. In support of this, the phenotypic changes observed
in P. aeruginosa isolates collected during different periods
of chronic infection from CF patients, included loss of fla-
gella or pilus mediated motility, loss of O antigen compo-
nents of the LPS, as well as appearance of auxotrophic
variants [39,41,44].
Biofilm formation is a multistep process requiring par-
ticipation of structural appendages, such as flagella and
type IV pili [44-47]. Recently, we showed that the flagel-
lum plays a direct role, as an adhesin, in S. maltophilia
adhesion to IB3-1 bronchial cells [17].
To test whether variations in biofilm formation we
observed in S. maltophilia could be due to altered activ-
ities of these structural appendages, we measured the
swimming and twitching abilities of the tested isolates.
Although most of the isolates tested were able to move
by swimming and twitching motilities, a lack of both
motilities was observed in 4 (8.5%) non-CF strains and 5
(12.2%) CF strains. Of these 9 non-motile strains, only 2
CF strains were unable to form biofilm, thus suggesting
that in S. maltophilia,a sw e l la sP. aeruginosa [48],
motility is not an absolute requirement for biofilm for-
mation [48]. It is worthy of note that both swimming
and twitching motilities were positively correlated with
biofilm levels in CF group only. Taken together, our
observations indicate that, although not involved in the
initial attachment of S. maltophilia,f l a g e l l aa n dt y p eI V
pili play a critical role in biofilm development in the CF
isolates, thus suggesting the existence of a peculiar
mechanism involved in the control of biofilm formation
in the CF lung.
The molecular mechanisms of biofilm formation have
not been extensively studied in S. maltophilia. Recently,
Fouhy et al. [18] described in S. maltophilia ac e l l - c e l l
signaling mediated by a diffusible signal factor (DSF, cis-
11-methyl-2-dodecenoic acid) whose synthesis is fully
dependent on rpfF. The rpfF mutant showed severely
reduced motility, altered LPS profiles and decreased bio-
film formation [18]. Huang et al. [19] found that alteration
in lipopolysaccharide (LPS), caused by the rmlA mutation,
contributed to changes in flagella and type IV pili, thus
interfering with motility, attachment, and biofilm forma-
tion [19]. A bifunctional spgM-encoded enzyme with both
phosphoglucomutase (PGM) and phosphomannomutase
activities was also found in S. maltophilia [20]. Since spgM
gene is a homologue of the algC gene, responsible for the
production of a PGM associated with LPS and alginate
biosynthesis in P. aeruginosa, it is plausible to hypothesize
an involvement of this gene also in S. maltophilia biofilm
formation.
In the present study we also focused our efforts on the
relationship between biofilm formation and the presence of
rpfF, rmlA and spgM genes. Our results showed that
rmlA
-/spgM
+/rpfF
+ and rmlA
+/spgM
+/rpfF
- genotypes are
significantly associated to CF and non-CF groups, respec-
tively. Furthermore, we found a significant association
between the detection of these genes and the biofilm
expression profiles, indicating that strong biofilm-producer
isolates are significantly associated to both genotypes.
Overall, our results may endorse the central role of
spgM gene in S. maltophilia biofilm formation ability,
whose presence is significantly associated to a strong
biofilm formation, both in non-CF and CF strains. On
the contrary, the contribution of rpfF and rmlA is differ-
ent on the basis of the group considered, thus confirm-
ing that biofilm formation is differently regulated in CF
and non-CF strains.
The hallmark of the infected CF lung is a chronic
neutrophil-dominated airway inflammation, and
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Page 11 of 16cytokine release [15,49]. Activated neutrophils and
macrophages are major sources of oxygen free radicals
including hydrogen peroxide. Jobsis et al. [50] recently
showed that in CF children with acute infective pulmon-
ary exacerbations exhaled H2O2 levels were higher than
those found in healthy children.
Starting from these evidences we evaluated S. maltophi-
lia sensitivity to oxidative stress by exposure to H2O2 on
solid agar. Our results revealed that CF isolates exhibited a
higher level of susceptibility than the non-CF strains to
this particular ROI species. As already stated by Head &
Yu [51] with regard to P. aeruginosa CF isolates, it could
also be possible in S. maltophilia CF isolates an impaired
production of superoxide dismutase, catalase or peroxi-
dase, thus explaining their limited ability to survive and
proliferate under in vitro oxidative stress.
The virulence of S. maltophilia from different sources
was evaluated by using an aerogenic acute lung infection
mouse model we recently described [15]. Although pul-
monary eradication on day 3 p.e. resulted high (> 99%)
for all strains tested, Sm111 CF and Sm46 non-CF blood
isolates were markedly less capable of being cleared than
non-CF respiratory ones. The apparent disagreement
between these findings and the higher susceptibility to
H2O2 exhibited by CF isolates is probably due to the fact
that neutrophil migration from the bloodstream to the
lungs occurs in the early hours following infection. No
correlation was found between in vitro biofilm formation
and in vivo lung colonization, reasonably because the
aerosol mouse model we used simulates an acute infec-
tion condition caused by planktonic cells, thus not allow-
ing biofilm formation. Contrary to the findings by
Waters et al [4], our results suggested that S. maltophilia
CF strains were more immunostimulatory than non-CF
ones with regard to TNF-a - a potent proinflammatory
cytokine that induces neutrophil and macrophage activa-
tion - and KC - a keratinocyte-derived chemoattractant
for neutrophils. This is a very important feature in the
initial colonization of the airways and development of
pneumonia. Further in vivo studies employing an ade-
quate number of isolates are needed to clarify the clinical
significance of our results.
Conclusions
Our results showed that S. maltophilia CF strains signif-
icantly differ from non-CF ones in some phenotypic
traits. Considering that adaptability is the key to suc-
cessful colonization of an environmental niche, these
particular responses taken characteristically by CF iso-
lates could be the biological price to evade the hostile
and heterogeneous CF lung environments. In fact, the
CF lung environment, representing a more extreme
environment to adapt to than other clinical ones, could
tax the cellular resources of CF strains to a greater
extent than those of the non-CF clinical isolates, thus
resulting in the selection of a “CF phenotype” for S.
maltophilia. The elucidation of molecular mechanisms
underlying these phenotypic differences might be rele-
vant to the identification of new targets for designing
rational and effective methods to combat and eradicate
S. maltophilia infection.
Methods
Bacterial isolates and growth conditions
Overall, 98 S. maltophilia isolates were investigated: 41
strains collected from the sputa of CF patients attending
the CF Unit at “Bambino Gesù” Children’s Hospital and
Research Institute of Rome; 47 strains collected from dif-
ferent sites (30 from respiratory tract, 10 from blood, and
7 from swabs) in non-CF patients attending “Bambino
Gesù” Children Hospital of Rome, or “Spirito Santo”
Hospital of Pe scara; and 10 strains (ENV) isolated in
Czech Republic from several environmental sources
(paddy, soil, rhizosphere tuberous roots, and waste
water). Since in severely ill chronic obstructive pulmon-
ary disease (COPD) patients P. aeruginosa clones similar
to those in CF persists [52], patients with COPD were
not enrolled in the present study. All clinical isolates
represented non-consecutive strains isolated from differ-
ent patients, except for 2 CF patients with 7 and 3 iso-
lates, respectively. The isolates were identified as
S. maltophilia by biochemical tests using manual (API
20-NE System; BioMérieux, Marcy-L’Etoile, France) or
automated (Vitek; BioMérieux) systems, then stored at
-80°C until use when they were grown at 37°C (and also
at 25°C, in the case of ENV strains) in Trypticase Soy
broth (TSB; Oxoid SpA; Garbagnate M.se, Milan, Italy)
or Mueller-Hinton agar (MHA; Oxoid) plates unless
otherwise noted.
Genetic relatedness by PFGE and cluster analysis
After digestion of DNA with the restriction enzyme XbaI
as previously described [24,27,28], PFGE was carried out
as follows: initial switch time and final switch time were
5 and 35 sec, respectively; DNA fragments were run with
a temperature of 12°C for 20 h at 6.0 V/cm with an
included angle of 120°. Isolates with identical PFGE pat-
terns were assigned to the same PFGE type and subtype.
Isolates differing by one to three bands were assigned to
different PFGE subtypes but to the same PFGE type and
were considered genetically related. Isolates with PFGE
patterns differing by more than 4 bands were considered
genetically unrelated and were assigned to different
PFGE types. PFGE types were analyzed with BioNumerics
software for Windows (version 2.5; Applied Maths,
Ghent, Belgium). The DNA banding patterns were nor-
malized with bacteriophage lambda concatemer ladder
standards. Comparison of the banding patterns was
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coefficient. A tolerance of 1.5% in band position was
applied during DNA patterns comparison.
Biofilm formation assay
Overnight cultures in TSB were corrected with fresh
TSB to an OD550 of 1.00 (corresponding to about 1 ×
10
9 CFU/ml). Two-hundred microliters of 1:100 diluted
inoculum were dispensed to each well of a sterile flat-
bottom polystyrene tissue culture 96-wells microtiter
(Iwaki, Bibby srl; Milan, Italy) and incubated at 37°C for
24 h. Biofilm formation by ENV strains was also
assessed at 25°C. Non-adherent cells were removed by
being washed three times in sterile PBS (pH 7.3; Sigma-
Aldrich Co; Milan, Italy), and biofilm biomass was then
measured by crystal violet assay. Briefly, biofilm samples
were fixed for 1 h at 60°C, stained for 5 min at RT with
200 μl Hucker-modified crystal violet, then rinsed in
standing water and allowed to dry. Biofilm samples were
estained with 250 μl of 33% glacial acetic acid for
15 min, and the optical density at 492 nm (OD492)w a s
read. Considering a low cut-off (ODc)r e p r e s e n t e db y
3×SD above the mean OD of control wells, strains were
classified into the following categories: no biofilm pro-
ducer (OD ≤ ODc), weak biofilm producer (ODc <O D
≤ 2×O D c), moderate biofilm producer (2 × ODc <O D
≤ 4×O D c), and strong biofilm producer (4 × ODc <
OD) [53].
Measurement of growth rate
Two-hundred microliters of the 1:100 diluted standar-
dized inoculum were dispensed in each well of a micro-
titer plate, and OD570 readings were taken every 15 min
for a total time of 15 h by a microplate reader (Spectra-
Max 190; Molecular Devices Inc.; Sunnyvale, CA, USA).
Considering the exponential growth phase selected on a
graph of ln OD570 versus time, mean generation time
(MGT) was calculated as follows: MGT = ln2/μ,w h e r e
μ (growth rate) = (lnOD t - lnODt0)/t.
Swimming and twitching motilities
Motility assays were performed according to the method
described by Rashid et al. [54], with some modifications.
i) Swimming assay: a single colony from an overnight
MHA-growth was inoculated at the surface of swim-
ming agar (10 g/liter tryptone, 5 g/liter NaCl, 3 g/liter
agar); after inoculation, the plates were then wrapped to
prevent dehydration and incubated at 37°C for 24 h, and
results were expressed as diameter (mm) of growth
zone. ii) Twitching motility: a single colony from an
overnight MHA-growth was inoculated, by using an
inoculation needle, to the bottom of the Petri dish plate
containing twitching agar (1% TSB solidified with 1%
agar); after incubation at 37°C for 72 h, agar was
r e m o v e da n dt h ez o n eo fm o t i l i t ya tt h ea g a r / P e t r id i s h
interface was stained with crystal violet and measured in
millimeters.
Sensitivity to oxidative stress
Assays were carried out by a disk assay adapted by Has-
sett et al. [55]. Briefly, 100-μl aliquots from TSB cultures
in mid-log or stationary phases of growth were uniformly
spread on TSA plates containing 2% agar. Sterile filter
paper 7-mm diameter disks (Oxoid) were placed on TSA
surface, and the disks were spotted, in triplicate on each
plate, with 10 μlo f1 . 5 %H 2O2. The diameter of the zone
of growth inhibition around each disk was measured
after 24 h of incubation at 37°C.
CLSM
Biofilm samples, prepared as stated above, were fixed in
formaldehyde-paraformaldehyde, and stained with propi-
dium iodide (PI; Molecular Probes Inc.; Eugene, OR,
USA) and concanavalin A (ConA, Alexa Fluor 647 con-
jugate; Molecular Probes Inc.). CLSM analysis was per-
formed with an LSM 510 META laser scanning
microscope attached to an Axioplan II microscope (Carl
Zeiss SpA; Arese, Milan, Italy). The excitation wave-
lengths were 458 [Argon laser], and 543 nm [He-Ne
laser], and emission wavelengths were 488, and 615 nm
for PI and ConA, respectively. Depth measurements
were taken at regular intervals across the width of the
device. To determine the structure of the biofilms, a ser-
ies of horizontal (x-y) optical sections were taken
throughout the full length of the biofilm. Confocal
images of blue (ConA) and red (PI) fluorescence were
conceived simultaneously using a track mode. Images
were captured and processed for display using Adobe
Photoshop (Adobe Systems Italia, Rome, Italy) software.
PCR-based genotyping for rmlA, spgM, and rpfF
Bacterial DNA was isolated by using the High Pure PCR
Template Preparation Kit (Roche Diagnostics S.p.A,
Milan, Italy). Purified DNA was amplified and visualized
on 2% agarose gel. PCR oligonucleotides were respectively
5’- GCAAGGTCATCGACCTGG-3’ and 5’-TTGCCGTC
GTAGAAGTACAGG-3’ (82 bp) for rmlA,5 ’-GCTTC
ATCGAGGGCTACTACC-3’ and 5’-ATGCACGATCT
TGCCGC-3’ (80 bp) for spgM and, finally, 5’-CTGGTCGA
CATCGTGGTG-3’ and 5’-TGATCCGCATCATTT-
CATGC-3’ (151 bp) for rpfF. All PCRs were carried out in
30 μl volumes with 10 mM Tris (pH 8.3), 2.5 mM MgCl2,
200 mM dNTP, 1.25 U of Taq-pol (EuroClone S.p.A.,
Milan, Italy), 0.5 μMo fe a c hp ri m e r ,a n d3μlo fD N A
extract. Amplification conditions were as follows: 30 cycles
of 60°C for 20 sec, 72°C for 30 sec, and 94°C for 20 sec. To
verify the specificity of the amplification test a pool of 21
PCR products was directly sequenced using the ABI Prism
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Prism 310 Genetic Analyzer (Applied Biosystems).
S. maltophilia aerosol infection mouse model
The virulence of selected strains from diverse clinical
settings - including CF (no biofilm producer Sm111
strain, and strong biofilm producer Sm122 strain) and
non-CF (strong biofilm producer Sm170 and Sm174
strains) respiratory specimens, as well as blood speci-
mens (strong biofilm producer Sm46 and Sm188 strains)
- was comparatively evaluated by using an aerogenic
infection mouse model [15]. All procedures involving
mice were reviewed and approved by the Animal Care
and Use Committee of “G. d’Annunzio” University of
Chieti-Pescara. Eight DBA-2 inbred, specific pathogen-
free mice (Charles River Laboratories Italia srl, Calco,
Italy) were exposed for 60 min to the nebulisation of a
standardized bacterial suspension (1.6 × 10
11 CFU/ml)
prepared in PBS (Sigma-Aldrich). In each group, four
mice were sacrificed by carbon dioxide at t = 1 h and t
= 3 days post-exposure. For quantitative bacteriology
analysis, 10-fold dilution series of homogenized lungs
were plated on MHA for counting. For cytokine mea-
surements, a protease inhibitors cocktail (Protease Inhi-
bitor Cocktail kit; Pierce, Rockford, IL, USA) was added
to the lung samples immediately after collection. Lung
homogenates were centrifuged (1,500 × g, 4°C, 10 min),
then the supernatants were assayed for TNF-a and KC
(Keratinocyte-derived Cytokine) levels by a multiplexing
sandwich-ELISA system based on chemiluminescent
detection (SearchLight Chemiluminescent Array Kits;
Endogen, Rockford, IL, USA), according to the manufac-
turer’s recommendations. The detection limit for TNF-a
and KC was 12.5 pg/ml and 6.0 pg/ml, respectively. The
number of colonies for each lung and cytokine levels
were normalized according to the wet weight of lung
tissue, and showed as CFU/mg or pg/mg lung tissue,
respectively.
Statistical analysis
All experiments were performed at least in triplicate and
repeated on two different occasions. Statistical analysis
of results was conducted with GraphPad Prism version
4.00 (GraphPad software Inc.; San Diego, CA, USA),
considering as statistically significant a p value < 0.05.
Parametric (ANOVA-test followed by Bonferroni’sm u l -
tiple comparison test) or non-parametric (Kruskal-
Wallis test followed by Dunn’s multiple comparison
test) tests were performed when data were normally dis-
tributed or not, respectively. Differences between fre-
quencies were assessed by Fisher’se x a c tt e s t .T h e
Pearson’s correlation coefficient was calculated to deter-
mine the association between two variables. Analysis of
Molecular Variance (AMOVA), as implemented in the
Arlequin 2005 software [56], was performed to analyze
frequencies of genotypes based on rmlA, spgM, and rpfF
detection. For all calculations, significance was assessed
by 1,000 permutations. The F-statistic (Fst) approach
[57] was applied to verify statistical differences in geno-
type distributions among S. maltophilia CF, non-CF and
environmental strains. Genetic networks were generated
using the median-joining algorithm implemented in
NETWORK 4.516 software (Fluxus Technology Ltd).
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